結果ページ13 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
- {{country.name}}
- すべての国
- 米国 (1011)
- オーストラリア (58)
- オーストリア (16)
- ベルギー (7)
- ブラジル (16)
- カナダ (83)
- 中国 (94)
- デンマーク (6)
- フィンランド (4)
- フランス (41)
- ドイツ (737)
- 香港 (46)
- インド (19)
- アイルランド (1)
- イスラエル (19)
- イタリア (4)
- 日本 (37)
- メキシコ (28)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (14)
- ポーランド (9)
- ロシア (2)
- 韓国 (10)
- スペイン (4)
- スウェーデン (70)
- スイス (11)
- 台湾 (67)
- タイ (2)
- トルコ (1)
- イギリス (69)
全取引所
- {{item.name}}
- 全取引所
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
バイオテクノロジー (2608)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| United Therapeutics Corporation UTH.F | $224 244.86 USD |
+1.96
|
$10.54B 11.52B USD | $30 32.79 USD | $220.1 240.6 USD | $224 244.86 USD | $10.54B 11.52B USD | 12.13 | $18.46 20.18 USD | |
| Bio-Techne Corporation TE1.F | $64 69.96 USD |
0
|
$10.06B 11B USD | $2 2.19 USD | $64 69.96 USD | $64 69.96 USD | $10.06B 11B USD | 49.61 | $1.29 1.41 USD | |
| Bio-Techne Corporation T1CH34.SA | $11.45 2.32 USD |
0
|
$54B 10.94B USD | $0 0 USD | $0 0 USD | $0 0 USD | $54B 10.94B USD | 47.70 | $0.24 0.05 USD | |
| Legend Biotech Corporation 9LB.F | $49.8 54.44 USD |
-2.35
|
$9.06B 9.9B USD | $10 10.93 USD | $49.8 54.44 USD | $51 55.75 USD | $9.06B 9.9B USD | 0 | -$2.74 -2.9 USD | |
| Roivant Sciences Ltd. 87S.F | $10.05 10.99 USD |
+1.25
|
$8.23B 8.99B USD | $1K 1.09K USD | $9.98 10.91 USD | $10.05 10.99 USD | $8.23B 8.99B USD | 2.04 | $4.91 5.37 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| Ascendis Pharma A/S A71.F | $141 154.13 USD |
-0.7
|
$7.98B 8.73B USD | $70 76.52 USD | $141 154.13 USD | $141 154.13 USD | $7.98B 8.73B USD | 0 | -$8.54 -9.3 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Ascendis Pharma A/S A1SN34.SA | $48.42 9.81 USD |
0
|
$42.11B 8.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $42.11B 8.54B USD | 0 | -$46.71 -9.4 USD | |
| Viking Therapeutics, Inc. 1VT.F | $65.52 71.62 USD |
-0.18
|
$7.22B 7.89B USD | $85 92.92 USD | $64.98 71.03 USD | $66.5 72.69 USD | $7.22B 7.89B USD | 0 | -$0.85 -0.9 USD | |
| Innovent Biologics, Inc. 6IB.F | $4.28 4.68 USD |
+0.94
|
$7.15B 7.82B USD | $520 568.43 USD | $4.28 4.68 USD | $4.46 4.88 USD | $7.15B 7.82B USD | 0 | -$0.09 -0.09 USD | |
| Cytokinetics, Incorporated KK3A.F | $68 74.33 USD |
+0.74
|
$7.11B 7.77B USD | $30 32.79 USD | $68 74.33 USD | $68 74.33 USD | $7.11B 7.77B USD | 0 | -$5.08 -5.5 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $900 53.29 USD |
0
|
$131.18B 7.77B USD | $0 0 USD | $900 53.29 USD | $900 53.29 USD | $131.18B 7.77B USD | 0 | -$42.65 -2.5 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $3.3 3.61 USD |
0
|
$6.89B 7.53B USD | $420 459.12 USD | $3.3 3.61 USD | $3.3 3.61 USD | $6.89B 7.53B USD | 16.50 | $0.2 0.22 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $1.64 1.8 USD |
+0.32
|
$6.89B 7.53B USD | $800 874.51 USD | $1.64 1.8 USD | $1.64 1.8 USD | $6.89B 7.53B USD | 16.44 | $0.1 0.11 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $92 100.57 USD | $21.09 23.05 USD | $21.09 23.05 USD | $6.79B 7.42B USD | 23.17 | $0.91 0.99 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $105.65 115.49 USD |
+0.71
|
$6.59B 7.2B USD | $9 9.84 USD | $105.15 114.94 USD | $105.65 115.49 USD | $6.59B 7.2B USD | 18.60 | $5.68 6.21 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.38 — |
+4.58
|
$7.2B — | $500 — | $0.38 — | $0.38 — | $7.2B — | 38.28 | $0.01 — | |
| Vaxcyte, Inc. 5VA.F | $60.5 66.13 USD |
+4.31
|
$6.56B 7.17B USD | $20 21.86 USD | $60.5 66.13 USD | $60.5 66.13 USD | $6.56B 7.17B USD | 0 | -$3.86 -4.2 USD | |
| Vaxcyte, Inc. 5VA.MU | $60.5 66.13 USD |
+3.42
|
$6.56B 7.17B USD | $10 10.93 USD | $60.5 66.13 USD | $60.5 66.13 USD | $6.56B 7.17B USD | 0 | -$3.86 -4.2 USD | |
| Exelixis, Inc. EX9.F | $20.94 22.89 USD |
-3.99
|
$6.45B 7.05B USD | $180 196.76 USD | $20.94 22.89 USD | $20.94 22.89 USD | $6.45B 7.05B USD | 34.32 | $0.61 0.67 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $52.95 57.88 USD |
+1.42
|
$6.38B 6.98B USD | $18 19.68 USD | $51.56 56.36 USD | $52.95 57.88 USD | $6.38B 6.98B USD | 0 | -$4.15 -4.5 USD | |
| Sino Biopharmaceutical SBHMY | $7.2 — |
0
|
$6.77B — | $16 — | $7.2 — | $7.2 — | $6.77B — | 25.71 | $0.28 — | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.32 0.35 USD |
-6.37
|
$6.11B 6.67B USD | $13.7K 14.97K USD | $0.32 0.35 USD | $0.32 0.35 USD | $6.11B 6.67B USD | 32.02 | $0.01 0.01 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $39.55 43.23 USD |
-0.63
|
$5.76B 6.3B USD | $30 32.79 USD | $39.55 43.23 USD | $39.55 43.23 USD | $5.76B 6.3B USD | 0 | -$2.38 -2.6 USD | |
| Revolution Medicines, Inc. 42Z.F | $34.8 38.04 USD |
+2.96
|
$5.73B 6.26B USD | $600 655.88 USD | $34.8 38.04 USD | $34.8 38.04 USD | $5.73B 6.26B USD | 0 | -$3.6 -3.9 USD | |
| Blueprint Medicines Corporation 2L9.F | $84 91.82 USD |
-1.45
|
$5.14B 5.62B USD | $85 92.92 USD | $84 91.82 USD | $88 96.2 USD | $5.14B 5.62B USD | 0 | -$7.8 -8.5 USD | |
| Akeso, Inc. 4RY.F | $5.7 6.23 USD |
-0.87
|
$5.1B 5.57B USD | $92 100.57 USD | $5.7 6.23 USD | $5.85 6.39 USD | $5.1B 5.57B USD | 18.38 | $0.31 0.34 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| Zealand Pharma A/S ZLDPF | $83 — |
-2.46
|
$5.28B — | $2.58K — | $82.94 — | $85.25 — | $5.28B — | 0 | -$1.79 — | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Krystal Biotech, Inc. 4KB.F | $167.45 183.05 USD |
+2.98
|
$4.77B 5.22B USD | $40 43.73 USD | $167.45 183.05 USD | $167.8 183.43 USD | $4.77B 5.22B USD | 452.56 | $0.37 0.4 USD | |
| Krystal Biotech, Inc. 4KB.SG | $167.2 182.77 USD |
+0.42
|
$4.77B 5.21B USD | $0 0 USD | $167.2 182.77 USD | $167.2 182.77 USD | $4.77B 5.21B USD | 451.89 | $0.37 0.4 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $25.82 28.22 USD |
+3.45
|
$4.76B 5.21B USD | $200 218.63 USD | $25.82 28.22 USD | $26.22 28.66 USD | $4.76B 5.21B USD | 0 | -$3.68 -4.02 USD | |
| Abcam ABCZF | $22.25 — |
0
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| Halozyme Therapeutics, Inc. HALO.MX | $680 40.26 USD |
0
|
$86.4B 5.12B USD | $0 0 USD | $680 40.26 USD | $680 40.26 USD | $86.4B 5.12B USD | 21.27 | $31.96 1.89 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $221.8 242.46 USD |
-2.68
|
$4.65B 5.08B USD | $10 10.93 USD | $221.8 242.46 USD | $232.9 254.59 USD | $4.65B 5.08B USD | 0 | -$18.62 -20.3 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $36.6 40.01 USD |
+0.52
|
$4.65B 5.08B USD | $100 109.31 USD | $36.6 40.01 USD | $36.6 40.01 USD | $4.65B 5.08B USD | 18.67 | $1.96 2.14 USD | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $83,300 62.88 USD |
-3.92
|
$6.52T 4.92B USD | $91.57K 69.12 USD | $82,900 62.58 USD | $86,000 64.92 USD | $6.52T 4.92B USD | 0 | $0 0 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $83.1 90.84 USD |
+1.9
|
$4.26B 4.66B USD | $12 13.12 USD | $82.45 90.13 USD | $83.1 90.84 USD | $4.26B 4.66B USD | 25.96 | $3.2 3.5 USD | |
| Financière de Tubize SA FTD.F | $91.5 100.02 USD |
+1.67
|
$4.16B 4.55B USD | $45 49.19 USD | $91.5 100.02 USD | $91.5 100.02 USD | $4.16B 4.55B USD | 46.21 | $1.98 2.16 USD | |
| Financière de Tubize SA FTD.SG | $91.9 100.46 USD |
+0.22
|
$4.16B 4.55B USD | $0 0 USD | $91.8 100.35 USD | $91.9 100.46 USD | $4.16B 4.55B USD | 46.41 | $1.98 2.16 USD | |
| Insmed Incorporated IM8N.F | $26.6 29.08 USD |
+0.76
|
$3.95B 4.32B USD | $20 21.86 USD | $26.6 29.08 USD | $26.6 29.08 USD | $3.95B 4.32B USD | 0 | -$4.98 -5.4 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $60 65.59 USD |
+0.84
|
$3.93B 4.3B USD | $67 73.24 USD | $60 65.59 USD | $60.5 66.13 USD | $3.93B 4.3B USD | 0 | -$0.59 -0.6 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $47.2 51.6 USD |
-1.26
|
$3.89B 4.25B USD | $25 27.33 USD | $47.2 51.6 USD | $47.2 51.6 USD | $3.89B 4.25B USD | 0 | -$7.69 -8.4 USD | |
| Genscript Biotech GNNSF | $2 — |
0
|
$4.25B — | $4.88K — | $2 — | $2 — | $4.25B — | 0 | -$0.05 — | |
| Insmed Incorporated IM8N.SG | $26 28.42 USD |
-1.52
|
$3.86B 4.22B USD | $0 0 USD | $26 28.42 USD | $26.6 29.08 USD | $3.86B 4.22B USD | 0 | -$4.98 -5.4 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| ALK-Abelló A/S 4AJ0.F | $16.75 18.31 USD |
+0.9
|
$3.69B 4.04B USD | $250 273.28 USD | $16.75 18.31 USD | $16.75 18.31 USD | $3.69B 4.04B USD | 57.75 | $0.29 0.32 USD | |
| ALK-Abelló A/S AKBLF | $18.4 — |
0
|
$3.96B — | $633 — | $18.4 — | $18.4 — | $3.96B — | 57.50 | $0.32 — | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $6.95 7.6 USD |
-0.71
|
$3.6B 3.93B USD | $100 109.31 USD | $6.95 7.6 USD | $6.95 7.6 USD | $3.6B 3.93B USD | 8.58 | $0.81 0.89 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $44.8 48.97 USD |
+5.16
|
$3.49B 3.82B USD | $100 109.31 USD | $44.8 48.97 USD | $44.8 48.97 USD | $3.49B 3.82B USD | 0 | -$3.44 -3.7 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Iovance Biotherapeutics, Inc. 2LB.F | $12.23 13.37 USD |
+6.21
|
$3.42B 3.73B USD | $645 705.07 USD | $12.23 13.37 USD | $12.23 13.37 USD | $3.42B 3.73B USD | 0 | -$1.76 -1.9 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Syngene International Limited SYNGENE.BO | $748.4 9.05 USD |
+2.23
|
$299.91B 3.63B USD | $97.67K 1.18K USD | $736.35 8.91 USD | $767.75 9.29 USD | $299.91B 3.63B USD | 60.25 | $12.42 0.15 USD | |
| Genscript Biotech Corporation G51.F | $1.52 1.66 USD |
+2.7
|
$3.23B 3.53B USD | $900 983.82 USD | $1.52 1.66 USD | $1.52 1.66 USD | $3.23B 3.53B USD | 0 | -$0.04 -0.04 USD | |
| ImmunityBio, Inc. 26CA.F | $4.67 5.1 USD |
-16.31
|
$3.23B 3.53B USD | $100 109.31 USD | $4.67 5.1 USD | $5.69 6.22 USD | $3.23B 3.53B USD | 0 | -$1.07 -1.1 USD | |
| SK bioscience Co.,Ltd. 302440.KS | $59,200 44.69 USD |
-1.5
|
$4.55T 3.43B USD | $29.48K 22.25 USD | $58,900 44.46 USD | $59,800 45.14 USD | $4.55T 3.43B USD | 0 | $0 0 USD | |
| Amicus Therapeutics, Inc. AM6.F | $10.4 11.37 USD |
0
|
$3.07B 3.36B USD | $500 546.57 USD | $10.4 11.37 USD | $10.4 11.37 USD | $3.07B 3.36B USD | 0 | -$0.48 -0.5 USD | |
| Axsome Therapeutics, Inc. 19X.F | $62.78 68.63 USD |
-3.74
|
$3.05B 3.34B USD | $30 32.79 USD | $62.78 68.63 USD | $66.4 72.58 USD | $3.05B 3.34B USD | 0 | -$4.92 -5.3 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $40 43.73 USD |
+1.52
|
$3.02B 3.3B USD | $40 43.73 USD | $40 43.73 USD | $40 43.73 USD | $3.02B 3.3B USD | 0 | -$2.54 -2.7 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $40 43.73 USD |
+3.63
|
$2.98B 3.26B USD | $420 459.12 USD | $40 43.73 USD | $40 43.73 USD | $2.98B 3.26B USD | 0 | -$1.83 -2.0004 USD | |
| IDEAYA Biosciences, Inc. 30J.SG | $39.6 43.29 USD |
-0.5
|
$2.95B 3.23B USD | $0 0 USD | $39.4 43.07 USD | $39.6 43.29 USD | $2.95B 3.23B USD | 0 | -$1.83 -2.0004 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $23.83 26.05 USD |
+1.53
|
$2.95B 3.23B USD | $20 21.86 USD | $23.83 26.05 USD | $23.83 26.05 USD | $2.95B 3.23B USD | 0 | -$2.58 -2.8 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $1 1.09 USD | $44.18 48.29 USD | $44.47 48.61 USD | $2.93B 3.2B USD | 0 | -$1.92 -2.09 USD | |
| VitaSpring Biomedical VSBC | $15 — |
0
|
$3.1B — | $200 — | $15 — | $15 — | $3.1B — | 0 | $0 — | |
| Immunocore Holdings plc 6YG.MU | $54.5 59.58 USD |
+0.93
|
$2.72B 2.97B USD | $13 14.21 USD | $54.5 59.58 USD | $54.5 59.58 USD | $2.72B 2.97B USD | 0 | -$1.32 -1.4 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $16.19 17.7 USD |
-1.19
|
$2.67B 2.92B USD | $260 284.22 USD | $16.19 17.7 USD | $16.19 17.7 USD | $2.67B 2.92B USD | 0 | -$0.34 -0.3 USD | |
| Immunocore Holdings plc 6YG.F | $53 57.94 USD |
-3.64
|
$2.64B 2.89B USD | $50 54.66 USD | $53 57.94 USD | $54.5 59.58 USD | $2.64B 2.89B USD | 0 | -$1.33 -1.4 USD | |
| MorphoSys AG MOR2.F | $16.4 17.93 USD |
+0.61
|
$2.56B 2.79B USD | $50 54.66 USD | $16.4 17.93 USD | $16.4 17.93 USD | $2.56B 2.79B USD | 0 | -$1.38 -1.5 USD | |
| MorphoSys AG MOR.VI | $67.65 73.95 USD |
+0.07
|
$2.56B 2.79B USD | $0 0 USD | $67.65 73.95 USD | $67.65 73.95 USD | $2.56B 2.79B USD | 0 | -$5.53 -6.04 USD | |
| Camurus AB (publ) 7CA.F | $44.28 48.4 USD |
+1.65
|
$2.55B 2.79B USD | $27 29.51 USD | $44.28 48.4 USD | $44.28 48.4 USD | $2.55B 2.79B USD | 68.12 | $0.65 0.71 USD | |
| Celldex Therapeutics, Inc. TCE2.F | $37.8 41.32 USD |
+5
|
$2.48B 2.71B USD | $85 92.92 USD | $37.8 41.32 USD | $37.8 41.32 USD | $2.48B 2.71B USD | 0 | -$2.72 -2.9 USD | |
| Denali Therapeutics Inc. 4DN.MU | $17.8 19.46 USD |
+3.19
|
$2.48B 2.71B USD | $74 80.89 USD | $17.8 19.46 USD | $17.8 19.46 USD | $2.48B 2.71B USD | 0 | -$0.99 -1.08 USD | |
| Denali Therapeutics Inc. 4DN.F | $17.79 19.44 USD |
+4.62
|
$2.47B 2.71B USD | $31 33.89 USD | $17.79 19.44 USD | $17.79 19.44 USD | $2.47B 2.71B USD | 0 | -$0.99 -1.08 USD | |
| BB Biotech AG Ord BBZA.F | $43.55 47.61 USD |
-0.34
|
$2.4B 2.62B USD | $2.05K 2.24K USD | $43.5 47.55 USD | $44.65 48.81 USD | $2.4B 2.62B USD | 0 | -$3.86 -4.2 USD | |
| Merus N.V. 2GH.F | $39.6 43.29 USD |
+3.66
|
$2.32B 2.54B USD | $20 21.86 USD | $39.6 43.29 USD | $39.8 43.51 USD | $2.32B 2.54B USD | 0 | -$2.8 -3.06 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $38.6 42.2 USD |
+1.05
|
$2.32B 2.54B USD | $50 54.66 USD | $38.6 42.2 USD | $39.4 43.07 USD | $2.32B 2.54B USD | 0 | -$2.98 -3.2 USD | |
| Corcept Therapeutics Incorporated HTD.F | $22.07 24.13 USD |
+0.82
|
$2.29B 2.51B USD | $485 530.17 USD | $22.07 24.13 USD | $22.07 24.13 USD | $2.29B 2.51B USD | 25.07 | $0.88 0.96 USD | |
| Intellia Therapeutics, Inc. 38I.F | $22.88 25.01 USD |
+0.22
|
$2.2B 2.4B USD | $325 355.27 USD | $22.88 25.01 USD | $23.3 25.47 USD | $2.2B 2.4B USD | 0 | -$5.05 -5.5 USD | |
| Vericel Corporation ATQP.F | $45 49.19 USD |
-0.88
|
$2.18B 2.38B USD | $10 10.93 USD | $45 49.19 USD | $45 49.19 USD | $2.18B 2.38B USD | 0 | -$0.07 -0.07 USD | |
| Galapagos GLPGF | $35.52 — |
0
|
$2.34B — | $12.6K — | $35.52 — | $35.52 — | $2.34B — | 0 | -$0.06 — | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | $23.62 25.82 USD |
+4.61
|
$2.14B 2.34B USD | $120 131.18 USD | $23.55 25.74 USD | $23.62 25.82 USD | $2.14B 2.34B USD | 0 | -$2.72 -2.9 USD | |
| TG Therapeutics, Inc. NKB2.F | $13.65 14.92 USD |
+0.72
|
$2.11B 2.3B USD | $80 87.45 USD | $13.65 14.92 USD | $13.65 14.92 USD | $2.11B 2.3B USD | 170.59 | $0.08 0.09 USD | |
| Geron Corporation GON.F | $3.49 3.81 USD |
+10.46
|
$2.05B 2.24B USD | $1K 1.09K USD | $3.49 3.81 USD | $3.49 3.81 USD | $2.05B 2.24B USD | 0 | -$0.3 -0.3 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $661 722.56 USD | $25 27.33 USD | $25.73 28.13 USD | $1.99B 2.18B USD | 45.17 | $0.56 0.61 USD | |
| Maravai LifeSciences Holdings, Inc. MAR.F | $7.8 8.53 USD |
-1.27
|
$1.97B 2.15B USD | $580 634.02 USD | $7.75 8.47 USD | $7.95 8.69 USD | $1.97B 2.15B USD | 0 | -$0.84 -0.9 USD | |
| Galapagos NV GLPG.VI | $28.96 31.66 USD |
-0.14
|
$1.91B 2.09B USD | $0 0 USD | $28.96 31.66 USD | $28.96 31.66 USD | $1.91B 2.09B USD | 0 | -$0.06 -0.06 USD | |
| BioArctic AB (publ) 0RV2.IL | $213.5 20.84 USD |
+8.08
|
$21.36B 2.08B USD | $1.34K 131.19 USD | $0 0 USD | $0 0 USD | $21.36B 2.08B USD | 69.54 | $3.07 0.3 USD | |
| Galapagos NV G1LP34.SA | $7.75 1.57 USD |
-1.27
|
$10.26B 2.08B USD | $0 0 USD | $0 0 USD | $0 0 USD | $10.26B 2.08B USD | 0 | -$0.33 -0.06 USD | |
| Galapagos NV GXE.F | $28.78 31.46 USD |
+0.56
|
$1.9B 2.07B USD | $251 274.38 USD | $28.68 31.35 USD | $29 31.7 USD | $1.9B 2.07B USD | 0 | -$0.06 -0.06 USD | |
| Galapagos NV GXEA.F | $27.6 30.17 USD |
0
|
$1.88B 2.05B USD | $150 163.97 USD | $27.6 30.17 USD | $27.6 30.17 USD | $1.88B 2.05B USD | 0 | -$0.06 -0.06 USD | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $4.56 4.98 USD |
-2.15
|
$1.83B 2B USD | $682 745.52 USD | $4.56 4.98 USD | $4.56 4.98 USD | $1.83B 2B USD | 14.70 | $0.31 0.34 USD | |
| Syndax Pharmaceuticals, Inc. 1T3.F | $20.4 22.3 USD |
+2
|
$1.73B 1.9B USD | $100 109.31 USD | $20.4 22.3 USD | $20.4 22.3 USD | $1.73B 1.9B USD | 0 | -$2.78 -3.03 USD | |
| 3SBio Inc. 83B.F | $0.6899 0.75 USD |
+0.74
|
$1.73B 1.89B USD | $1K 1.09K USD | $0.6899 0.75 USD | $0.6899 0.75 USD | $1.73B 1.89B USD | 8.56 | $0.08 0.09 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $14.56 15.92 USD |
0
|
$1.72B 1.88B USD | $350 382.6 USD | $14.56 15.92 USD | $14.56 15.92 USD | $1.72B 1.88B USD | 24.67 | $0.59 0.64 USD | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||